Clinical communication in inflammatory bowel disease: a systematic literature review protocol

Neda Karimi; Alison Rotha Moore; Annabelle Lukin; Ria Kanazaki; Astrid-Jane Williams; Susan Connor

doi:10.1136/bmjopen-2020-039503

Clinical communication in inflammatory bowel disease: a systematic literature review protocol

Neda Karimi, Alison Rotha Moore, Annabelle Lukin, Ria Kanazaki, Astrid-Jane Williams, Susan Connor

Research output: Contribution to journal › Article

4 Citations (Scopus)

63 Downloads (Pure)

Abstract

INTRODUCTION: Evidence regarding effective communication between clinicians and patients with inflammatory bowel disease (IBD) is limited. Studies that investigate clinical communication in IBD are much fewer in number than studies that investigate the perceptions of patients and clinicians about communication in clinical encounters. The current review aims to identify, organise and summarise systematically what is currently known about (1) the characteristics of interactions between clinicians who manage IBD and patients with IBD, and (2) how clinical discussion affects health outcomes in IBD. METHODS AND ANALYSIS: Scopus, PubMed, Embase, Communication Abstracts, Health & Society, Linguistics and Language Behavior Abstracts and PsycINFO will be systematically searched for studies that investigate the characteristics of IBD clinical interactions during recorded consultations, from earliest available dates within each database to May 2020. A specifically developed quality assessment tool, grounded in linguistic theory, will be used to critically assess the evidence. In addition, a data extraction template will be developed and utilised to provide a description of the characteristics of IBD clinical communication as well as an estimation of its effect on health outcomes in a narrative synthesis. ETHICS AND DISSEMINATION: Ethical review and approval is not required for this systematic review as no primary data will be collected. The results will be published in peer-reviewed journals and presented at academic conferences. PROSPERO REGISTRATION NUMBER: International Prospective Register of Systematic Reviews (PROSPERO) on 28 April 2020 (registration number: CRD42020169657).

Original language	English
Article number	e039503
Pages (from-to)	1-7
Number of pages	7
Journal	BMJ Open
Volume	10
Issue number	11
DOIs	https://doi.org/10.1136/bmjopen-2020-039503
Publication status	Published - 4 Nov 2020

Bibliographical note

Copyright the Author(s) 2020. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

clinical communication
clinical encounter
communication
inflammatory bowel disease
systematic review

Access to Document

10.1136/bmjopen-2020-039503Licence: CC BY-NC

Publisher version (open access)Final published version, 286 KBLicence: CC BY-NC

Cite this

@article{4157836cea6547258fef0f8cd1516a46,

title = "Clinical communication in inflammatory bowel disease: a systematic literature review protocol",

abstract = "INTRODUCTION: Evidence regarding effective communication between clinicians and patients with inflammatory bowel disease (IBD) is limited. Studies that investigate clinical communication in IBD are much fewer in number than studies that investigate the perceptions of patients and clinicians about communication in clinical encounters. The current review aims to identify, organise and summarise systematically what is currently known about (1) the characteristics of interactions between clinicians who manage IBD and patients with IBD, and (2) how clinical discussion affects health outcomes in IBD. METHODS AND ANALYSIS: Scopus, PubMed, Embase, Communication Abstracts, Health & Society, Linguistics and Language Behavior Abstracts and PsycINFO will be systematically searched for studies that investigate the characteristics of IBD clinical interactions during recorded consultations, from earliest available dates within each database to May 2020. A specifically developed quality assessment tool, grounded in linguistic theory, will be used to critically assess the evidence. In addition, a data extraction template will be developed and utilised to provide a description of the characteristics of IBD clinical communication as well as an estimation of its effect on health outcomes in a narrative synthesis. ETHICS AND DISSEMINATION: Ethical review and approval is not required for this systematic review as no primary data will be collected. The results will be published in peer-reviewed journals and presented at academic conferences. PROSPERO REGISTRATION NUMBER: International Prospective Register of Systematic Reviews (PROSPERO) on 28 April 2020 (registration number: CRD42020169657).",

keywords = "clinical communication, clinical encounter, communication, inflammatory bowel disease, systematic review",

author = "Neda Karimi and Moore, {Alison Rotha} and Annabelle Lukin and Ria Kanazaki and Astrid-Jane Williams and Susan Connor",

note = "Copyright the Author(s) 2020. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher. ",

year = "2020",

month = nov,

day = "4",

doi = "10.1136/bmjopen-2020-039503",

language = "English",

volume = "10",

pages = "1--7",

journal = "BMJ Open",

issn = "2044-6055",

publisher = "British Medical Journal Publishing Group",

number = "11",

}

TY - JOUR

T1 - Clinical communication in inflammatory bowel disease

T2 - a systematic literature review protocol

AU - Karimi, Neda

AU - Moore, Alison Rotha

AU - Lukin, Annabelle

AU - Kanazaki, Ria

AU - Williams, Astrid-Jane

AU - Connor, Susan

N1 - Copyright the Author(s) 2020. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2020/11/4

Y1 - 2020/11/4

N2 - INTRODUCTION: Evidence regarding effective communication between clinicians and patients with inflammatory bowel disease (IBD) is limited. Studies that investigate clinical communication in IBD are much fewer in number than studies that investigate the perceptions of patients and clinicians about communication in clinical encounters. The current review aims to identify, organise and summarise systematically what is currently known about (1) the characteristics of interactions between clinicians who manage IBD and patients with IBD, and (2) how clinical discussion affects health outcomes in IBD. METHODS AND ANALYSIS: Scopus, PubMed, Embase, Communication Abstracts, Health & Society, Linguistics and Language Behavior Abstracts and PsycINFO will be systematically searched for studies that investigate the characteristics of IBD clinical interactions during recorded consultations, from earliest available dates within each database to May 2020. A specifically developed quality assessment tool, grounded in linguistic theory, will be used to critically assess the evidence. In addition, a data extraction template will be developed and utilised to provide a description of the characteristics of IBD clinical communication as well as an estimation of its effect on health outcomes in a narrative synthesis. ETHICS AND DISSEMINATION: Ethical review and approval is not required for this systematic review as no primary data will be collected. The results will be published in peer-reviewed journals and presented at academic conferences. PROSPERO REGISTRATION NUMBER: International Prospective Register of Systematic Reviews (PROSPERO) on 28 April 2020 (registration number: CRD42020169657).

AB - INTRODUCTION: Evidence regarding effective communication between clinicians and patients with inflammatory bowel disease (IBD) is limited. Studies that investigate clinical communication in IBD are much fewer in number than studies that investigate the perceptions of patients and clinicians about communication in clinical encounters. The current review aims to identify, organise and summarise systematically what is currently known about (1) the characteristics of interactions between clinicians who manage IBD and patients with IBD, and (2) how clinical discussion affects health outcomes in IBD. METHODS AND ANALYSIS: Scopus, PubMed, Embase, Communication Abstracts, Health & Society, Linguistics and Language Behavior Abstracts and PsycINFO will be systematically searched for studies that investigate the characteristics of IBD clinical interactions during recorded consultations, from earliest available dates within each database to May 2020. A specifically developed quality assessment tool, grounded in linguistic theory, will be used to critically assess the evidence. In addition, a data extraction template will be developed and utilised to provide a description of the characteristics of IBD clinical communication as well as an estimation of its effect on health outcomes in a narrative synthesis. ETHICS AND DISSEMINATION: Ethical review and approval is not required for this systematic review as no primary data will be collected. The results will be published in peer-reviewed journals and presented at academic conferences. PROSPERO REGISTRATION NUMBER: International Prospective Register of Systematic Reviews (PROSPERO) on 28 April 2020 (registration number: CRD42020169657).

KW - clinical communication

KW - clinical encounter

KW - communication

KW - inflammatory bowel disease

KW - systematic review

UR - http://www.scopus.com/inward/record.url?scp=85095675257&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2020-039503

DO - 10.1136/bmjopen-2020-039503

M3 - Article

C2 - 33148752

AN - SCOPUS:85095675257

SN - 2044-6055

VL - 10

SP - 1

EP - 7

JO - BMJ Open

JF - BMJ Open

IS - 11

M1 - e039503

ER -

Clinical communication in inflammatory bowel disease: a systematic literature review protocol

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this